03 - OUR PLATFORM
Biologics
can do more
Our modular approach enables unmatched integration of binders, complex bispecific formatting, and modification – at scale
We can work with antibody fragments and other proteins – even natural ligands
Limitless modularity
We use building block protein technology that is compatible with any assets – from traditional antibody fragments to small peptides. LiliumX’s platform can freely integrate any biologics development
Breaking barriers
Traditional bispecific development is either scalable or flexible – not both. LiliumX’s building block approach breaks free of this restriction, enabling development of sophisticated multispecific designs with custom modifications
Target new space
LiliumX deploys a scalable pipeline for internal and collaborative discovery of bispecific antibodies, from protein design to robotic screening and AI analysis
We don’t just look for ‘better’ drugs. We look for unprecedented drugs, by leveraging platform engineering, post-translational modification and in-format screening
Elevate your assets
Our Universal Assembly Platform can integrate any existing biologics asset, mixing and matching them. We can repurpose biologics on our platform or test them against components in our toolbox to identify improved or novel characteristics
From multi-paratopic targeting to multi-receptor targeting. Reach out at info@liliumx.com to learn more about partnering opportunities.
